vs
Artisan Partners Asset Management Inc.（APAM）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Artisan Partners Asset Management Inc.的1.9倍（$622.0M vs $335.5M），Artisan Partners Asset Management Inc.净利率更高（35.2% vs 34.4%，领先0.8%），Artisan Partners Asset Management Inc.同比增速更快（12.9% vs 4.8%），过去两年Artisan Partners Asset Management Inc.的营收复合增速更高（12.7% vs 4.6%）
阿蒂森伙伴资产管理公司（Artisan Partners）是总部位于美国威斯康星州密尔沃基的资产管理机构，除美国本土外，还在都柏林、香港、伦敦、新加坡、悉尼设有办公室，为全球客户提供专业的资产管理服务。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
APAM vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$335.5M
营收增速更快
APAM
高出8.2%
4.8%
净利率更高
APAM
高出0.8%
34.4%
两年增速更快
APAM
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $335.5M | $622.0M |
| 净利润 | $118.1M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 39.2% | 62.4% |
| 净利率 | 35.2% | 34.4% |
| 营收同比 | 12.9% | 4.8% |
| 净利润同比 | 34.9% | 2.9% |
| 每股收益（稀释后） | $1.36 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APAMRPRX
| Q4 25 | $335.5M | $622.0M | ||
| Q3 25 | $301.3M | $609.3M | ||
| Q2 25 | $282.7M | $578.7M | ||
| Q1 25 | $277.1M | $568.2M | ||
| Q4 24 | $297.1M | $593.6M | ||
| Q3 24 | $279.6M | $564.7M | ||
| Q2 24 | $270.8M | $537.3M | ||
| Q1 24 | $264.4M | $568.0M |
净利润APAMRPRX
| Q4 25 | $118.1M | $214.2M | ||
| Q3 25 | $66.8M | $288.2M | ||
| Q2 25 | $67.6M | $30.2M | ||
| Q1 25 | $61.1M | $238.3M | ||
| Q4 24 | $87.5M | $208.2M | ||
| Q3 24 | $73.0M | $544.0M | ||
| Q2 24 | $57.6M | $102.0M | ||
| Q1 24 | $59.5M | $4.8M |
营业利润率APAMRPRX
| Q4 25 | 39.2% | 62.4% | ||
| Q3 25 | 33.8% | 70.1% | ||
| Q2 25 | 28.2% | 36.3% | ||
| Q1 25 | 31.2% | 94.0% | ||
| Q4 24 | 36.7% | 60.9% | ||
| Q3 24 | 33.3% | — | ||
| Q2 24 | 32.0% | 50.2% | ||
| Q1 24 | 29.4% | -13.0% |
净利率APAMRPRX
| Q4 25 | 35.2% | 34.4% | ||
| Q3 25 | 22.2% | 47.3% | ||
| Q2 25 | 23.9% | 5.2% | ||
| Q1 25 | 22.1% | 41.9% | ||
| Q4 24 | 29.5% | 35.1% | ||
| Q3 24 | 26.1% | 96.3% | ||
| Q2 24 | 21.3% | 19.0% | ||
| Q1 24 | 22.5% | 0.8% |
每股收益（稀释后）APAMRPRX
| Q4 25 | $1.36 | $0.49 | ||
| Q3 25 | $0.93 | $0.67 | ||
| Q2 25 | $0.94 | $0.07 | ||
| Q1 25 | $0.82 | $0.55 | ||
| Q4 24 | $0.99 | $0.46 | ||
| Q3 24 | $1.03 | $1.21 | ||
| Q2 24 | $0.80 | $0.23 | ||
| Q1 24 | $0.84 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | $190.0M | $9.0B |
| 股东权益账面价值 | $438.8M | $9.7B |
| 总资产 | $1.6B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资APAMRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务APAMRPRX
| Q4 25 | $190.0M | $9.0B | ||
| Q3 25 | $190.0M | $8.9B | ||
| Q2 25 | $200.0M | $8.0B | ||
| Q1 25 | $200.0M | $7.6B | ||
| Q4 24 | $200.0M | $7.6B | ||
| Q3 24 | $200.0M | $7.6B | ||
| Q2 24 | $200.0M | $7.6B | ||
| Q1 24 | $200.0M | $6.1B |
股东权益APAMRPRX
| Q4 25 | $438.8M | $9.7B | ||
| Q3 25 | $402.1M | $9.6B | ||
| Q2 25 | $381.8M | $9.5B | ||
| Q1 25 | $356.5M | $9.8B | ||
| Q4 24 | $388.9M | $10.3B | ||
| Q3 24 | $372.1M | $10.3B | ||
| Q2 24 | $341.2M | $9.8B | ||
| Q1 24 | $320.3M | $9.9B |
总资产APAMRPRX
| Q4 25 | $1.6B | $19.6B | ||
| Q3 25 | $1.6B | $19.3B | ||
| Q2 25 | $1.4B | $18.3B | ||
| Q1 25 | $1.4B | $17.6B | ||
| Q4 24 | $1.6B | $18.2B | ||
| Q3 24 | $1.6B | $18.0B | ||
| Q2 24 | $1.5B | $17.7B | ||
| Q1 24 | $1.5B | $16.1B |
负债/权益比APAMRPRX
| Q4 25 | 0.43× | 0.92× | ||
| Q3 25 | 0.47× | 0.93× | ||
| Q2 25 | 0.52× | 0.84× | ||
| Q1 25 | 0.56× | 0.78× | ||
| Q4 24 | 0.51× | 0.74× | ||
| Q3 24 | 0.54× | 0.74× | ||
| Q2 24 | 0.59× | 0.78× | ||
| Q1 24 | 0.62× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $172.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $171.6M | — |
| 自由现金流率自由现金流/营收 | 51.2% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | 1.46× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $420.6M | — |
8季度趋势，按日历期对齐
经营现金流APAMRPRX
| Q4 25 | $172.0M | $827.1M | ||
| Q3 25 | $40.4M | $702.6M | ||
| Q2 25 | $50.9M | $364.0M | ||
| Q1 25 | $157.9M | $596.1M | ||
| Q4 24 | $372.8M | $742.5M | ||
| Q3 24 | $112.8M | $703.6M | ||
| Q2 24 | $75.9M | $658.2M | ||
| Q1 24 | $147.0M | $664.6M |
自由现金流APAMRPRX
| Q4 25 | $171.6M | — | ||
| Q3 25 | $40.4M | — | ||
| Q2 25 | $50.9M | — | ||
| Q1 25 | $157.7M | — | ||
| Q4 24 | $371.3M | — | ||
| Q3 24 | $112.4M | — | ||
| Q2 24 | $75.2M | — | ||
| Q1 24 | $146.9M | — |
自由现金流率APAMRPRX
| Q4 25 | 51.2% | — | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | 18.0% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 125.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q2 24 | 27.8% | — | ||
| Q1 24 | 55.6% | — |
资本支出强度APAMRPRX
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.0% | — |
现金转化率APAMRPRX
| Q4 25 | 1.46× | 3.86× | ||
| Q3 25 | 0.60× | 2.44× | ||
| Q2 25 | 0.75× | 12.06× | ||
| Q1 25 | 2.58× | 2.50× | ||
| Q4 24 | 4.26× | 3.57× | ||
| Q3 24 | 1.54× | 1.29× | ||
| Q2 24 | 1.32× | 6.45× | ||
| Q1 24 | 2.47× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APAM
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
